Placebo-Controlled Study of the Efficacy and Safety of BG00012 in Pediatric Subjects With Relapsing-Remitting Multiple Sclerosis (RRMS)

Clinical trial NCT02428218 · WITHDRAWN

Trial details

NCT number: NCT02428218
Sponsor: Biogen
Status: WITHDRAWN
Phase: Phase 3
Study type: INTERVENTIONAL

Relapsing-Remitting Multiple Sclerosis Relapsing Forms of Multiple Sclerosis

Start date: 2016-05-01
Primary completion: 2027-01-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.